![Charles Bramlage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Bramlage
Directeur Général chez
Yamo Pharmaceuticals LLC
Profil
Mr. Charles J.
Bramlage is a Chief Executive Officer at Yamo Pharmaceuticals LLC.
He is on the Board of Directors at Clarametyx Biosciences, Inc. Mr. Bramlage was previously employed as an Independent Director by Eiger BioPharmaceuticals, Inc., an Independent Director by BioDelivery Sciences International, Inc., a President, Chief Executive Officer & Director by Pearl Therapeutics, Inc., a President-Pharmaceutical Products by Covidien Ltd., a President-North America & EMEA by Valeant Pharmaceuticals International Corp., a President & Chief Executive Officer by BattellePharma Inc., a VP-Respiratory Global Commercial Development by GlaxoSmithKline Plc, and a Principal by Merck & Co., Inc. He also served on the board at Locus Biosciences, Inc. He received his undergraduate degree from Fisher College of Business and an MBA from the University of Dayton.
Postes actifs de Charles Bramlage
| Sociétés | Poste | Début |
|---|---|---|
Clarametyx Biosciences, Inc.
 Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Directeur/Membre du Conseil | - |
Yamo Pharmaceuticals LLC
 Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur Général | - |
Anciens postes connus de Charles Bramlage
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Directeur/Membre du Conseil | 04/01/2018 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Membre du Conseil | 07/12/2017 |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Directeur Général | 01/11/2016 |
Covidien Unlimited Co.
 Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Corporate Officer/Principal | 01/01/2011 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Corporate Officer/Principal | 01/07/2008 |
Formation de Charles Bramlage
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops aerosol devices | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Dayton
 University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Health Technology |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Fisher College of Business
 Fisher College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Develops AI-enabled precision medicine for infectious diseases and immunology | Technology Services |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Health Technology |
